Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights
揭开层面：通过分析师见解探索Axsome疗法
Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Axsome Therapeutics (NASDAQ:AXSM) in the last three months.
在过去三个月中，有18位分析师公布了对Axsome Therapeutics（纳斯达克股票代码：AXSM）的评级，提供了从看涨到看跌的不同视角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $131.89, a high estimate of $190.00, and a low estimate of $103.00. This current average has increased by 6.52% from the previous average price target of $123.82.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为131.89美元，最高估计为190.00美元，低估值为103.00美元。目前的平均价格较之前的平均目标价123.82美元上涨了6.52％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
A clear picture of Axsome Therapeutics's perception among...
通过对分析师近期行...
登录免费看全文
登录/注册